Lieven D.
- Country
- Belgium
- Department
- Pneumolgy
Research Overview
- Phase 2 Randomized Double‑Blind Study of VX-828/Deutivacaftor With and Without Tezacaftor in Adults with Cystic Fibrosis
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Camlipixant in Adults with Refractory or Unexplained Chronic Cough
- Efficacy and Safety of Taplucainium Chloride Inhalation Powder in Adults with Refractory or Unexplained Chronic Cough: A Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 10 of 96 partner sites.
Specializations
Respiratory Medicine
The investigator specializes in treating patients with chronic cough conditions, with particular emphasis on refractory chronic cough (RCC) and unexplained chronic cough (UCC).
- Chronic Cough Management
- Respiratory Disease Assessment
- Cough Frequency Evaluation
Their work encompasses long-term therapeutic approaches for persistent cough conditions resistant to standard treatments.
Therapeutic Innovation
The investigator focuses on evaluating novel therapeutic interventions for chronic cough, including inhalation-based treatments and innovative pharmaceutical compounds.
- Novel Cough Suppressants
- Respiratory Drug Delivery
- Treatment Efficacy Assessment
Their expertise extends to investigating extended-duration therapeutic protocols spanning up to 52 weeks.
Clinical Assessment
The investigator has developed expertise in objective cough monitoring and evaluation methodologies for respiratory conditions.
- 24-hour Cough Frequency Monitoring
- Long-term Safety Assessment
- Treatment Response Evaluation
Their research involves comprehensive monitoring of treatment outcomes in adult patients with chronic respiratory conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.